| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 31.01.1975 (18008
dage). |
Ingen historik.
| Branche | | Engroshandel med medicinalvarer og sygeplejeartikler (464610). |
| Sidst opdateret den 25.12.2007 og
angivet som gældende fra 01.01.2008 (5985
dage). |
| Historik | Start | Stop |
|---|
| Engroshandel med medicinalvarer og sygeplejeartikler (464610) | 01.01.2008 | |
| Engroshandel med medicinalvarer og sygeplejeartikler (514610) | 31.01.1975 | 31.12.2007 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 12.04.1989 (12823
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Telefonnummer | | 45266000. |
| Sidst opdateret den 03.10.2000 og
angivet som gældende fra 25.08.2000 (8670
dage). |
Ingen historik.
| Navne | | ELI LILLY DANMARK A/S. |
| Sidst opdateret den 18.03.2015 og
angivet som gældende fra 30.04.1993 (11344
dage). |
| Historik | Start | Stop |
|---|
| ELI LILLY DANMARK A/S | 30.04.1993 | |
| ELI LILLY DENMARK A/S | 23.03.1989 | 29.04.1993 |
| ELI LILLY AND COMPANY DENMARK ApS | 31.01.1975 | 22.03.1989 |
| Binavne | | ELI LILLY EXPORT A/S. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 12.04.1989 (12823
dage). |
| Historik | Start | Stop |
|---|
| ELI LILLY EXPORT A/S | 12.04.1989 | |
| GEMELLI A/S | 12.04.1989 | |
| ELANCO ANIMAL HEALTH A/S | 12.04.1989 | 31.08.2022 |
| GUIDANT A/S | 12.04.1989 | 15.01.1997 |
| CPI NORDEN A/S | 12.04.1989 | 01.12.1994 |
| DISTA PRODUCTS A/S | 12.04.1989 | 01.12.1994 |
| ELANCO A/S | 12.04.1989 | 14.11.1991 |
| Tegningsregel | | Selskabet tegnes af en direktør, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 22.05.2014 (3652
dage). |
| Fortolkning
(3 tegningsmuligheder)
| | 1 direktør |
| 2 bestyrelsesmedlemmer + |
| bestyrelsen |
Ingen historik.
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Virksomhedens regnskabsklasse:Regnskabsklasse C, stor virksomhed
Grundlag for konklusion (revision):Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Opinion
We have audited the financial statements of Eli Lilly Danmark A/S for the financial year 1 January - 31 December 2022, which comprise income statement, balance sheet, statement of changes in equity, cash flow statement and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2022 and of the results of the Company's operations and cash flows for the financial year 1 January - 31 December 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the Management's review.
Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
, Statement on the Management's review
Management is responsible for the Management's review.
Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration